Market Cap 76.23B
Revenue (ttm) 14.34B
Net Income (ttm) 4.50B
EPS (ttm) N/A
PE Ratio 18.90
Forward PE 19.06
Profit Margin 31.41%
Debt to Equity Ratio 0.06
Volume 774,600
Avg Vol 675,536
Day's Range N/A - N/A
Shares Out 105.72M
Stochastic %K 46%
Beta 0.30
Analysts Strong Sell
Price Target $874.75

Company Profile

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascul...

Industry: Biotechnology
Sector: Healthcare
Phone: 914 847 7000
Address:
777 Old Saw Mill River Road, Tarrytown, United States
judgeyoung2
judgeyoung2 May. 7 at 7:26 PM
$REGN if fianlimab is disappointing then they’ll prolly drop it on a friday morning
0 · Reply
logn
logn May. 7 at 2:57 AM
$REGN long term still
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 6 at 7:09 PM
$REGN $3B of buybacks going into this quarter- who do you think is going to win the battle?
0 · Reply
LabPsycho
LabPsycho May. 6 at 3:05 PM
$MAIA I am going to keep posting my idea on how to 5X THIO's potential market value until someone takes the baton and runs with it. My antibody ADC-THIO construct shown below based on my computational chemistry and molecular dynamic simulations, and the hypothesis / plausibility is supported by several peer reviewed articles and my own creative, scientifically sound input. In my earlier posts I also describe quick, easy, cost effective pilot studies one could do in a lab in one day to evaluate feasibility. Come on $REGN or $RHHBY - see the light.
1 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 2:59 PM
$REGN Current Stock Price: $722.14 Contracts to trade: $720.0 REGN May 08 2026 Call Entry: $5.90 Exit: $8.61 ROI: 46% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Norbitstock
Norbitstock May. 5 at 8:24 PM
$REGN dont panic. It will rise!! (He told me himself)
0 · Reply
DidYouReadThis
DidYouReadThis May. 5 at 2:49 PM
What was in the news or going on last time $REGN hit a 52 week low? How much (if any) of a dip do you predict if a potential blockbuster competitor receives potential FDA approval in May 2026 or potentially within 1.5 years? Do you think $REGN may dip below 500 within the next 5 years? Do you think opthalmic bevacizumab might receive FDA approval before or after the next presidential election? Do you think OTLK might take a slice of the wet AMD market and more one day? $PFE $LLY $PJP $MRK
0 · Reply
FuegoFiesta
FuegoFiesta May. 4 at 10:07 PM
$REGN $AON $ICE $SITM watchlist
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 4 at 3:15 PM
$REGN buybacks at work...
0 · Reply
bzgm
bzgm May. 3 at 6:30 PM
0 · Reply
Latest News on REGN
Regeneron price target lowered to $796 from $801 at Truist

2026-04-30T17:04:53.000Z - 7 days ago

Regeneron price target lowered to $796 from $801 at Truist


Regeneron price target lowered to $917 from $923 at Barclays

2026-04-30T09:52:25.000Z - 8 days ago

Regeneron price target lowered to $917 from $923 at Barclays


Regeneron Pharmaceuticals Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 9 days ago

Regeneron Pharmaceuticals Earnings Call Transcript: Q1 2026


Regeneron CEO on deal with Trump admin to lower drug prices

Apr 24, 2026, 10:30 AM EDT - 14 days ago

Regeneron CEO on deal with Trump admin to lower drug prices


FDA Approves First-Ever Gene Therapy to Restore Hearing

Apr 23, 2026, 1:42 PM EDT - 14 days ago

FDA Approves First-Ever Gene Therapy to Restore Hearing


FDA grants accelerated approval for Regeneron’s Otarmeni

2026-04-23T16:45:17.000Z - 14 days ago

FDA grants accelerated approval for Regeneron’s Otarmeni


FDA approves Regeneron's gene therapy for inherited deafness

Apr 23, 2026, 12:45 PM EDT - 14 days ago

FDA approves Regeneron's gene therapy for inherited deafness


Regeneron price target raised to $960 from $880 at TD Cowen

2026-04-23T12:37:10.000Z - 15 days ago

Regeneron price target raised to $960 from $880 at TD Cowen


Regeneron Pharmaceuticals Transcript: Status update

Apr 22, 2026, 8:30 AM EDT - 16 days ago

Regeneron Pharmaceuticals Transcript: Status update


Regeneron Announces Investor Conference Presentations

Apr 20, 2026, 4:05 PM EDT - 17 days ago

Regeneron Announces Investor Conference Presentations


Regeneron says it expects to avoid new US pharma tariffs

Apr 2, 2026, 2:27 PM EDT - 5 weeks ago

Regeneron says it expects to avoid new US pharma tariffs


Regeneron Pharmaceuticals Earnings Call Transcript: Q4 2025

Jan 30, 2026, 8:30 AM EST - 3 months ago

Regeneron Pharmaceuticals Earnings Call Transcript: Q4 2025


Regeneron beats quarterly profit estimates on Dupixent strength

Jan 30, 2026, 7:37 AM EST - 3 months ago

Regeneron beats quarterly profit estimates on Dupixent strength


Regeneron Pharmaceuticals Transcript: Study Update

Dec 10, 2025, 8:30 AM EST - 5 months ago

Regeneron Pharmaceuticals Transcript: Study Update


judgeyoung2
judgeyoung2 May. 7 at 7:26 PM
$REGN if fianlimab is disappointing then they’ll prolly drop it on a friday morning
0 · Reply
logn
logn May. 7 at 2:57 AM
$REGN long term still
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 6 at 7:09 PM
$REGN $3B of buybacks going into this quarter- who do you think is going to win the battle?
0 · Reply
LabPsycho
LabPsycho May. 6 at 3:05 PM
$MAIA I am going to keep posting my idea on how to 5X THIO's potential market value until someone takes the baton and runs with it. My antibody ADC-THIO construct shown below based on my computational chemistry and molecular dynamic simulations, and the hypothesis / plausibility is supported by several peer reviewed articles and my own creative, scientifically sound input. In my earlier posts I also describe quick, easy, cost effective pilot studies one could do in a lab in one day to evaluate feasibility. Come on $REGN or $RHHBY - see the light.
1 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 2:59 PM
$REGN Current Stock Price: $722.14 Contracts to trade: $720.0 REGN May 08 2026 Call Entry: $5.90 Exit: $8.61 ROI: 46% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Norbitstock
Norbitstock May. 5 at 8:24 PM
$REGN dont panic. It will rise!! (He told me himself)
0 · Reply
DidYouReadThis
DidYouReadThis May. 5 at 2:49 PM
What was in the news or going on last time $REGN hit a 52 week low? How much (if any) of a dip do you predict if a potential blockbuster competitor receives potential FDA approval in May 2026 or potentially within 1.5 years? Do you think $REGN may dip below 500 within the next 5 years? Do you think opthalmic bevacizumab might receive FDA approval before or after the next presidential election? Do you think OTLK might take a slice of the wet AMD market and more one day? $PFE $LLY $PJP $MRK
0 · Reply
FuegoFiesta
FuegoFiesta May. 4 at 10:07 PM
$REGN $AON $ICE $SITM watchlist
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 4 at 3:15 PM
$REGN buybacks at work...
0 · Reply
bzgm
bzgm May. 3 at 6:30 PM
0 · Reply
BioTechHealthX
BioTechHealthX May. 3 at 4:12 PM
$REGN Regeneron Pharmaceuticals, Inc. is gaining fresh momentum as analysts reiterate bullish ratings and highlight upcoming oncology catalysts—here’s why investors are paying attention. https://biotechhealthx.com/biotech-news/is-it-a-great-move-to-acquire-regeneron-pharmaceuticals-regn-shares/
0 · Reply
Edgebell
Edgebell May. 2 at 6:39 PM
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed May. 1 at 2:03 PM
$REGN institutions are accumulating here.
0 · Reply
BioTechHealthX
BioTechHealthX May. 1 at 5:10 AM
$ARWR $CORT $PTCT $REGN $VRTX Biotech is entering a new growth phase fueled by innovation and capital inflows. Here are the top 5 biotech stocks to buy now based on analyst ratings, profitability, and strategic positioning. https://biotechhealthx.com/biotech-news/top-5-best-biotech-stocks-wall-street-is-buying-aggressively-now/
0 · Reply
Edgebell
Edgebell May. 1 at 12:00 AM
$REGN showed up on the http://edgebell.io scanner today. Strong signals! Price > 200 SMA (Long-term bullishness) • Positive RSI Divergence (Momentum bottoming out) • Upcoming Catalyst (PDUFA/Earnings volatility) • Institutional Accumulation (Buy ratings from major desks like TD Cowen and Cantor Fitzgerald)
0 · Reply
flowerchefstocks
flowerchefstocks Apr. 30 at 10:15 PM
$REGN Read in this article that Regeneron bought Decibel Therapeutics. Not ab bad deal. They got their money back in about 2 years and have a whole platform to exploit. The FDA is hot on these orphan drug diseases. This article does quite a good job talking about how the FDA is telegraphing its approvals. It makes so much sense. Definitely worth the read. https://www.zerohedge.com/news/2026-04-30/makarys-new-fda-expose-corruption-buy-these-biotechs-now
0 · Reply
DidYouReadThis
DidYouReadThis Apr. 30 at 5:28 PM
$OTLK Was anyone surprised by Norse 8? Was week 12 surprising? $REGN $RHHBY $COR
2 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 30 at 4:59 PM
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 30 at 2:15 PM
$REGN like I said it's still a $800 stock.
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 30 at 1:40 AM
$REGN they are buying back $3B of stock to stop the short position on this as they should.
0 · Reply
Bazzzigar
Bazzzigar Apr. 29 at 9:55 PM
$REGN moved to ALNY...Hopefully an amazing ER tomorrow
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 29 at 8:22 PM
$REGN it's still a $800 stock
0 · Reply